Benjamin Schnack Rasmussen
Papers
1
Total Citations
4
H-Index
1
About
Benjamin Schnack Rasmussen is a clinical researcher specializing in urologic oncology, with a primary focus on renal cell carcinoma (RCC) treatment outcomes. His work centers on comparing surgical and ablative techniques for kidney cancer, particularly investigating renal function preservation following robot-assisted partial nephrectomy (RAPN) and percutaneous cryoablation (PCA). Rasmussen’s most-cited prospective study (2023, 4 citations) directly addresses the critical question of how baseline renal function influences post-treatment outcomes in clinical T1 RCC patients, providing valuable guidance for treatment selection. His research contributes to the growing evidence base for minimally invasive kidney-sparing approaches, helping urologists and interventional radiologists optimize patient counseling and procedural choice. By prospectively comparing functional outcomes between these two techniques, Rasmussen’s work supports personalized treatment decisions that balance oncologic control with renal preservation. His findings are particularly relevant given the increasing incidence of small renal masses and the importance of avoiding chronic kidney disease in cancer survivors. Through methodologically rigorous comparative effectiveness research, Rasmussen is advancing the evidence for nephron-sparing interventions in urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1